Roxburgh AD; Ritter A; Grech K; Slade T; Burns LA, 2011, Trends in Drug Use and Related Harms in Australia, 2001 to 2011, Original, Drug Policy Modelling Program, National Drug and Alcohol Research Centre, University of New South Wales, Sydney, NSW, http://ndarc.med.unsw.edu.au/resource/trends-drug-use-and-related-harms-australia-2001-2011-0

Chalmers JJ; Ritter A; Heffernan M; McDonnell GD, 2009, Modelling pharmacotherapy maintenance in Australia: Exploring affordability, availability, accessibility and quality using system dynamics., 1, Australian National Council on Drugs, Canberra

Ritter A; Chalmers JJ, 2009, Polygon: The many sides to the Australian opioid pharmacotherapy maintenance system, 1, Australian National Council on Drugs, Canberra

Ross JE; Teesson M; Darke S; Lynskey M; Ali R; Ritter A; Cooke R, 2004, Twelve Month Outcomes of Treatment for Heroin Dependence Findings from the Australian Treatment Outcome Study (ATOS), NDARC Technical Report No. 196, National Drug and Alcohol Research Centre, University of New South Wales, Sydney, NSW, Australia

Champion K; Newton N; Birrell LE; Teesson M, 2017, 'Primary Prevention for Alcohol and Other Drug Use among Australian Adolescents', in Ritter A; Lee N; King T (ed.), Drug Use in Australian Society, Oxford University Press Australia, pp. 124 - 143

Barratt MJ; Lenton S, 2017, 'Drugs and the internet', in Ritter A; King T; Lee N (ed.), Drug Use in Australian Society, Oxford University Press Australia, pp. 102 - 123

Ritter A; Chalmers J; Berends L, 2017, 'A methodology for estimating health expenditure on drug treatment: the Australian experience', in Drug treatment expenditure: a methodological overview, European Monitoring Centre for Drugs and Drug Addiction, Luxembourg, pp. 25 - 34, http://dx.doi.org/10.2810/052028

Ritter A; King T; Lee N, 2017, 'Introduction', in Ritter A; King T; Lee N (ed.), Drug Use in Australian Society, edn. 2nd, Oxford University Press Australia, Melbourne, pp. 1 - 19

Ritter A; Hughes CE; Hull P, 2016, 'Drug policy', in Kolind T; Thom B; Hunt G; Karch S; Thom B; White J (ed.), The SAGE handbook of drug & alcohol studies. Volume 1, Social science approaches, SAGE, Thousand Oaks, CA, pp. 135 - 163

Ritter A; Lancaster K, 2013, 'Policy models and influences on policy processes', in Ritter A; King T; Hamilton M (ed.), Drug Use in Australian Society, edn. 1, Oxford University Press, Australia, pp. 99 - 132, http://www.oup.com.au/titles/higher_ed/health_sciences/9780195518863

Ritter A, 2013, 'I2S Needs Theory as Well as a Toolkit', in Bammer G (ed.), Disciplining Interdisciplinarity: Integration and Implementation Sciences for Researching Complex Real-World Problems, ANU E Press, Canberra, ACT, pp. 313 - 318, http://epress.anu.edu.au/wp-content/uploads/2013/01/whole.pdf#page=337

King T; Ritter A; Hamilton M, 2013, 'Setting the scene', in Ritter A; King T; Hamilton M (ed.), Drug Use in Australian Society, edn. Military Strategy and Operational Art, Oxford University Press, Australia, pp. 3 - 26, http://www.oup.com.au/titles/higher_ed/health_sciences/9780195518863

Ritter A, 2011, 'Drug Treatment Programs', in Kleiman MAR; Hawdon JE (ed.), Encyclopedia of Drug Policy, edn. Original, SAGE Publications, Thousand Oaks, California, pp. 247 - 250, http://www.uk.sagepub.com/books/Book234211

Ritter A, 2011, 'Methadone', in Kleiman MAR; Hawdon JE (ed.), Encyclopedia of Drug Policy, edn. Original, SAGE Publications, Thousand Oaks, California, pp. 506 - 508, http://www.uk.sagepub.com/books/Book234211

Ritter A, 2011, 'Needle Exchange Programs', in Kleiman MAR; Hawdon JE (ed.), Encyclopedia of Drug Policy, edn. Original, SAGE Publications, Thousand Oaks, California, pp. 563 - 565, http://www.uk.sagepub.com/books/Book234211

Ritter A, 2011, 'Australia', in Kleiman MAR; Hawdon JE (ed.), Encyclopedia of Drug Policy, edn. Original, SAGE Publications, Thousand Oaks, California, pp. 75 - 77, http://www.uk.sagepub.com/books/Book234211

Bammer G; Strazdins L; McDonald D; Berry H; Ritter A; Deane P; van Kerkhoff L, 2010, 'Expanding the deliberations about the research-policy gap: useful ideas from the literature', in Bammer G; Michaux A; Sanson A (ed.), BRIDGING THE KNOW-DO GAP: KNOWLEDGE BROKERING TO IMPROVE CHILD WELLBEING, ANU E Press, Canberra, Australia, pp. 135 - 155, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000291465600012&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a

Lintzeris N; Clark N; Muhleisen P; Ritter A; Mattick RP, 2009, 'National clinical guidelines and procedures for the use of buprenorphine in the treatment of heroin dependence.', in Mattick RP; Ali R; Lintzeris N (ed.), Pharmacotherapies for Opioid Dependence Treatment, edn. 1, Informa Healthcare, London, UK, pp. 390 - 445

Bell JR; Kimber J; Lintzeris N; White J; Mattick RP; Ritter A, 2009, 'Clinical guidelines and procedures for the use of naltrexone in the opioid dependence.', in Mattick RP; Ali R; Lintzeris N (ed.), Pharmacotherapies for Opioid Dependence Treatment, edn. 1, Informa Healthcare, London, UK, pp. 446 - 474

Henry-Edwards S; Gowing L; White J; Ali RL; Lintzeris N; Bell JR; Ritter A; Quigley A, 2009, 'Clinical guidelines and procedures for the use of methadone in the maintenance treatment of opioid dependence', in Mattick RP; Ali R; Lintzeris N (ed.), Pharmacotherapies for Opioid Dependence Treatment, edn. 1, Informa Healthcare, London, UK, pp. 354 - 389

Gibson AE; Ritter A, 2009, 'Naltrexone maintenance treatment', in Mattick RP; Ali R; Lintzeris N (ed.), Pharmacotherapies for Opioid Dependence Treatment, edn. 1, Informa Healthcare, London, UK, pp. 252 - 281

Dunlop A; Petroulias D; Marope D; Khoo K; Kimber J; Ritter A; Burrell T; Osborn DA, 2009, 'Pharmacotherapies and pregnancy', in Mattick RP; Ali R; Lintzeris N (ed.), Pharmacotherapies for Opioid Dependence Treatment, edn. 1, Informa Healthcare, London, UK, pp. 282 - 329

Bammer G; Smithson M; Ritter A, 2008, 'The nature of uncertainty', in Bammer G; Smithson M (ed.), Uncertainty and Risk; Multidisciplinary Perspectives, Earthscan Publications, UK, pp. 289 - 303, http://dx.doi.org/10.4324/9781849773607

Smithson M; Bammer G; Ritter A, 2008, 'Uncertainty metaphors, motives and morals.', in Bammer G; Smithson M (ed.), Uncertainty and Risk; Multidisciplinary Perspectives, Earthscan Publications, UK, pp. 305 - 320, http://dx.doi.org/10.4324/9781849773607

Smithson M; Bammer G; Ritter A, 2008, 'Coping and manageing under uncertainty', in Uncertainty metaphors, motives and morals., Earthscan, London, pp. 321 - 333, http://dx.doi.org/10.4324/9781849773607

Ritter A, 2008, 'Heroin: Injected with uncertainty.', in Brammer G; Smithson M (ed.), Uncertainty: Mutidisciplinary perspectives on risk, Earthscan, London, pp. 157 - 169, http://dx.doi.org/10.4324/9781849773607

Dray A; Mazerolle L; Perez P; Ritter A, 2008, 'Drug law enforcement in an agent-based model:Simulating the disruption to street-level drug markets', in Liu L; Eck J (ed.), Artificial crime analysis systems: using computer simulations and geographic information systems, Idea Group Publishing, Hershey, PA, pp. 352 - 371, http://dx.doi.org/10.4018/978-1-59904-591-7.ch018

Perez P; Dray A; Ritter A; Dietze P; Moore T; Mazerolle L, 2006, 'SimDrug: A Multi-Agent System Tackling the Complexity of Illicit Drug Markets in Australia', in Perez P; Batten D (ed.), COMPLEX SCIENCE FOR A COMPLEX WORLD: EXPLORING HUMAN ECOSYSTEMS WITH AGENTS, AUSTRALIAN NATL UNIV, pp. 193 - 223, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000291158700015&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Curchin K; Weight T; Ritter A, 2022, 'Moral framings in the Australian parliamentary debate on drug testing of welfare recipients', Social Policy and Administration, vol. 56, pp. 409 - 422, http://dx.doi.org/10.1111/spol.12774

O'Reilly K; Kowalski M; Barratt MJ; Ritter A, 2022, 'Distinguishing personal use of drugs from drug supply: Approaches and challenges', International Journal of Drug Policy, vol. 103, pp. 103653, http://dx.doi.org/10.1016/j.drugpo.2022.103653

Ritter A; van de Ven K; Vuong T; Chalmers J; Dobbins T; Livingston M; Berends L, 2022, 'Are market mechanisms associated with alcohol and other drug treatment outcomes?', Addiction, vol. 117, pp. 1105 - 1116, http://dx.doi.org/10.1111/add.15681

Greer A; Bonn M; Shane C; Stevens A; Tousenard N; Ritter A, 2022, 'The details of decriminalization: Designing a non-criminal response to the possession of drugs for personal use', International Journal of Drug Policy, vol. 102, http://dx.doi.org/10.1016/j.drugpo.2022.103605

Sommerville K; Ritter A; Stephenson N, 2022, 'Pill testing policy: A comparative analysis using the Advocacy Coalition Framework', Drug and Alcohol Review, vol. 41, pp. 275 - 284, http://dx.doi.org/10.1111/dar.13352

Ritter A; McLauchlan L, 2022, 'Citizens’ juries and their role in improved alcohol policy: damp squib, or useful tool?', Drugs: Education, Prevention and Policy, pp. 1 - 12, http://dx.doi.org/10.1080/09687637.2022.2050185

Stirling R; Nathan S; Ritter A, 2022, 'Prioritizing measures to assess performance of drug treatment services: a Delphi process with funders, treatment providers and service-users', Addiction, http://dx.doi.org/10.1111/add.16038

Conigrave KM; Ali RL; Armstrong R; Chikritzhs TN; d’Abbs P; Harris MF; Hewlett N; Livingston M; Lubman DI; McKenzie A; O’Leary C; Ritter A; Wilson S; Grimmond M; Banks E, 2021, 'Revision of the Australian guidelines to reduce health risks from drinking alcohol', Medical Journal of Australia, vol. 215, pp. 518 - 524, http://dx.doi.org/10.5694/mja2.51336

Haber PS; Riordan BC; Winter DT; Barrett L; Saunders J; Hides L; Gullo M; Manning V; Day CA; Bonomo Y; Burns L; Assan R; Curry K; Mooney-Somers J; Demirkol A; Monds L; McDonough M; Baillie AJ; Clark P; Ritter A; Quinn C; Cunningham J; Lintzeris N; Rombouts S; Savic M; Norman A; Reid S; Hutchinson D; Zheng C; Iese Y; Black N; Draper B; Ridley N; Gowing L; Stapinski L; Taye B; Lancaster K; Stjepanović D; Kay-Lambkin F; Jamshidi N; Lubman D; Pastor A; White N; Wilson S; Jaworski AL; Memedovic S; Logge W; Mills K; Seear K; Freeburn B; Lea T; Withall A; Marel C; Boffa J; Roxburgh A; Purcell-Khodr G; Doyle M; Conigrave K; Teesson M; Butler K; Connor J; Morley KC, 2021, 'New Australian guidelines for the treatment of alcohol problems: an overview of recommendations', Medical Journal of Australia, vol. 215, pp. S3 - S32, http://dx.doi.org/10.5694/mja2.51254

Riordan BC; Winter DT; Barrett L; Ritter A; Lancaster K; Seear K; Butler K; Haber PS, 2021, 'Guidelines for the treatment of alcohol problems: an introduction', MEDICAL JOURNAL OF AUSTRALIA, vol. 215, pp. S3 - S5, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000703210100006&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Wilkinson C; Ritter A, 2021, 'Applying a ‘harm to others’ research framework to illicit drugs: political discourses and ambiguous policy implications', Addiction, vol. 116, pp. 1941 - 1946, http://dx.doi.org/10.1111/add.15243

Wilkinson C; Ritter A, 2021, 'Thinking beyond the individual, a response to commentaries', Addiction, vol. 116, pp. 1952 - 1953, http://dx.doi.org/10.1111/add.15605

Mellor R; Lancaster K; Ritter A, 2021, 'Recovery from alcohol problems in the absence of treatment: a qualitative narrative analysis', Addiction, vol. 116, pp. 1413 - 1423, http://dx.doi.org/10.1111/add.15288

Mellor R; Lancaster K; Ritter A, 2021, 'Examining untreated and treated alcohol problem resolution in an Australian online survey sample', Drug and Alcohol Review, http://dx.doi.org/10.1111/dar.13257

Ritter A, 2021, 'MENTAL HEALTH ONTOLOGIES: HOW WE TALK ABOUT MENTAL HEALTH, AND WHY IT MATTERS IN THE DIGITAL AGE', ADDICTION, vol. 116, pp. 2248 - 2249, http://dx.doi.org/10.1111/add.15418

Vuong T; Ritter A; Shanahan M; Ali R; Nguyen N; Minh KP, 2021, 'Quality of life as a predictor of time to heroin relapse among male residents following release from compulsory rehabilitation centres in Vietnam', Drug and Alcohol Review, vol. 40, pp. 296 - 306, http://dx.doi.org/10.1111/dar.13176

Madden A; Lancaster K; Ritter A; Treloar C, 2021, 'Making legitimacy: Drug user representation in United Nations drug policy settings', International Journal of Drug Policy, vol. 87, pp. 103014 - 103014, http://dx.doi.org/10.1016/j.drugpo.2020.103014

van de Ven K; Ritter A; Vuong T; Livingston M; Berends L; Chalmers J; Dobbins T, 2021, 'A comparison of structural features and vulnerability between government and nongovernment alcohol and other drug (AOD) treatment providers', Journal of Substance Abuse Treatment, vol. 132, pp. 108467, http://dx.doi.org/10.1016/j.jsat.2021.108467

Nielsen S; Picco L; Kowalski M; Sanfilippo P; Wood P; Larney S; Bruno R; Ritter A, 2020, 'Routine opioid outcome monitoring in community pharmacy: Outcomes from an open-label single-arm implementation-effectiveness pilot study', Research in Social and Administrative Pharmacy, vol. 16, pp. 1694 - 1701, http://dx.doi.org/10.1016/j.sapharm.2020.02.009

Stirling R; Ritter A; Rawstorne P; Nathan S, 2020, 'Contracting treatment services in Australia: Do measures adhere to best practice?', International Journal of Drug Policy, vol. 86, http://dx.doi.org/10.1016/j.drugpo.2020.102947

O'Reilly MJA; Hughes CE; Bright DA; Ritter A, 2020, 'Structural and functional changes in an Australian high-level drug trafficking network after exposure to supply changes', International Journal of Drug Policy, vol. 84, http://dx.doi.org/10.1016/j.drugpo.2020.102797

Hughes C; Hulme S; Ritter A, 2020, 'The relationship between drug price and purity and population level harm', Trends and Issues in Crime and Criminal Justice

Cox S; Moss AC; Ritter A, 2020, 'Editorial for special issue: Vulnerable groups: Addiction research, policy and practice', Addictive Behaviors, vol. 104, http://dx.doi.org/10.1016/j.addbeh.2019.106266

Shanahan M; Seddon J; Ritter A; De Abreu Lourenco R, 2020, 'Valuing families' preferences for drug treatment: a discrete choice experiment', Addiction, vol. 115, pp. 690 - 699, http://dx.doi.org/10.1111/add.14816

O'Keefe D; Ritter A; Stoove M; Hughes C; Dietze P, 2020, 'Harm reduction programs and policy in Australia: Barriers and enablers to effective implementation', Sucht, vol. 66, pp. 33 - 43, http://dx.doi.org/10.1024/0939-5911/a000641

Mellor R; Ritter A, 2020, 'Redressing responses to the treatment gap for people with alcohol problems: The overlooked role of untreated remission from alcohol problems', Sucht, vol. 66, pp. 21 - 30, http://dx.doi.org/10.1024/0939-5911/a000640

van de Ven K; Ritter A; Berends L; Chalmers J; Lancaster K, 2020, 'Perceptions of purchasing and payment mechanisms in alcohol and other drug treatment services in Australia: A qualitative study involving alcohol and other drug service providers and purchasers of treatment', Drug and Alcohol Review, vol. 39, pp. 189 - 197, http://dx.doi.org/10.1111/dar.13027

Rhodes T; Ritter A, 2020, 'Editing the International Journal of Drug Policy', International Journal of Drug Policy, vol. 76, http://dx.doi.org/10.1016/j.drugpo.2020.102664

van de Ven K; Ritter A; Roche A, 2020, 'Alcohol and other drug (AOD) staffing and their workplace: examining the relationship between clinician and organisational workforce characteristics and treatment outcomes in the AOD field', Drugs: Education, Prevention and Policy, vol. 27, pp. 1 - 14, http://dx.doi.org/10.1080/09687637.2019.1622649

Ritter A, 2020, 'Making drug policy in summer—drug checking in Australia as providing more heat than light', Drug and Alcohol Review, vol. 39, pp. 12 - 20, http://dx.doi.org/10.1111/dar.13018

Greer A; Ritter A, 2020, 'The legal regulation of drugs and role of government: Perspectives from people who use drugs', Drug and Alcohol Dependence, vol. 206, http://dx.doi.org/10.1016/j.drugalcdep.2019.107737

Strang J; McDonald R; Campbell G; Degenhardt L; Nielsen S; Ritter A; Dale O, 2019, 'Take-Home Naloxone for the Emergency Interim Management of Opioid Overdose: The Public Health Application of an Emergency Medicine', Drugs, vol. 79, pp. 1395 - 1418, http://dx.doi.org/10.1007/s40265-019-01154-5

Greer A; Ritter A, 2019, 'Harm reduction and the opioid crisis: Emerging policy challenges', International Journal of Drug Policy, vol. 71, pp. 139 - 141, http://dx.doi.org/10.1016/j.drugpo.2019.05.015

Mellor R; Lancaster K; Ritter A, 2019, 'Systematic review of untreated remission from alcohol problems: Estimation lies in the eye of the beholder', Journal of Substance Abuse Treatment, vol. 102, pp. 60 - 72, http://dx.doi.org/10.1016/j.jsat.2019.04.004

Lancaster K; Rhodes T; valentine K; Ritter A, 2019, 'A ‘promising tool’? A critical review of the social and ethico-political effects of wastewater analysis in the context of illicit drug epidemiology and drug policy', Current Opinion in Environmental Science and Health, vol. 9, pp. 85 - 90, http://dx.doi.org/10.1016/j.coesh.2019.06.006

Belackova V; Salmon AM; Day CA; Ritter A; Shanahan M; Hedrich D; Kerr T; Jauncey M, 2019, 'Drug consumption rooms: A systematic review of evaluation methodologies', Drug and Alcohol Review, vol. 38, pp. 406 - 422, http://dx.doi.org/10.1111/dar.12919

Ritter A; van de Ven K, 2019, 'Alcohol and other drug treatment commissioning and purchasing: Is it health care or social-welfare?', Drug and Alcohol Review, vol. 38, pp. 119 - 122, http://dx.doi.org/10.1111/dar.12871

Greer AM; Ritter A, 2019, '“It's about bloody time”: Perceptions of people who use drugs regarding drug law reform', International Journal of Drug Policy, vol. 64, pp. 40 - 46, http://dx.doi.org/10.1016/j.drugpo.2018.12.006

Ritter A; van de Ven K, 2019, 'Is health or social welfare the right question? Response to commentaries', Drug and Alcohol Review, vol. 38, pp. 129 - 130, http://dx.doi.org/10.1111/dar.12900

Ritter A; Chalmers J; Gomez M, 2019, 'Measuring Unmet Demand for Alcohol and Other Drug Treatment: The Application of an Australian Population-Based Planning Model', Journal of studies on alcohol and drugs. Supplement, pp. 42 - 50, http://dx.doi.org/10.15288/jsads.2019.s18.42

Ritter A; Mellor R; Chalmers J; Sunderland M; Lancaster K, 2019, 'Key Considerations in Planning for Substance Use Treatment: Estimating Treatment Need and Demand', Journal of Studies on Alcohol and Drugs, pp. 22 - 30, http://dx.doi.org/10.15288/jsads.2019.s18.22

Lancaster K; Ritter A; valentine K; Rhodes T, 2019, '"A more accurate understanding of drug use": A critical analysis of wastewater analysis technology for drug policy', International Journal of Drug Policy, vol. 63, pp. 47 - 55, http://dx.doi.org/10.1016/j.drugpo.2018.10.011

Lancaster K; Ritter A; Diprose R, 2018, 'Recasting Participation in Drug Policy', Contemporary Drug Problems, vol. 45, pp. 351 - 365, http://dx.doi.org/10.1177/0091450918776024

Tait RJ; Whetton S; Shanahan M; Cartwright K; Ferrante A; Gray D; Kaye S; McKetin R; Pidd K; Ritter A; Roche A; Allsop S, 2018, 'Quantifying the societal cost of methamphetamine use to Australia', International Journal of Drug Policy, vol. 62, pp. 30 - 36, http://dx.doi.org/10.1016/j.drugpo.2018.08.015

Nielsen S; Kowalski M; Wood P; Larney S; Bruno R; Shanahan M; Lenton S; Dietze P; Green T; Murnion B; Ritter A, 2018, 'Routine opioid outcome monitoring in community pharmacy: Pilot implementation study protocol.', Res Social Adm Pharm, http://dx.doi.org/10.1016/j.sapharm.2018.10.024

Ritter A; Hughes CE; Lancaster K; Hoppe R, 2018, 'Using the Advocacy Coalition Framework and Multiple Streams policy theories to examine the role of evidence, research and other types of knowledge in drug policy', Addiction, vol. 113, pp. 1539 - 1547, http://dx.doi.org/10.1111/add.14197

Ritter A; Lancaster K; Diprose R, 2018, 'Improving drug policy: The potential of broader democratic participation', International Journal of Drug Policy, vol. 55, pp. 1 - 7, http://dx.doi.org/10.1016/j.drugpo.2018.01.016

Vuong T; Ritter A; Shanahan M; Ali R; Nguyen N; Pham K; Vuong TTA; Le GM, 2018, 'Outcomes of compulsory detention compared to community-based voluntary methadone maintenance treatment in Vietnam', Journal of Substance Abuse Treatment, vol. 87, pp. 9 - 15, http://dx.doi.org/10.1016/j.jsat.2018.01.011

Barratt MJ; Bruno R; Ezard N; Ritter A, 2018, 'Pill testing or drug checking in Australia: Acceptability of service design features', Drug and Alcohol Review, vol. 37, pp. 226 - 236, http://dx.doi.org/10.1111/dar.12576

McSweeney T; Hughes C; Ritter A, 2018, 'The impact of compliance with a compulsory model of drug diversion on treatment engagement and reoffending', Drugs: Education, Prevention and Policy, vol. 25, pp. 56 - 66, http://dx.doi.org/10.1080/09687637.2016.1219695

Belackova V; Shanahan M; Ritter A, 2018, 'Mapping regulatory models for medicinal cannabis: A matrix of options', Australian Health Review, vol. 42, pp. 403 - 411, http://dx.doi.org/10.1071/AH16257

Seear K; Lancaster K; Ritter A, 2017, 'A new framework for evaluating the potential for drug law to produce stigma: Insights from an australian study', Journal of Law, Medicine and Ethics, vol. 45, pp. 596 - 606, http://dx.doi.org/10.1177/1073110517750599

Vuong T; Ritter A; Nguyen N; Ali R, 2017, 'Strengthening advocacy efforts with empirical evidence: A case example of the conduct, uptake and utilisation of research in drug policy decision-making in Vietnam', International Journal of Drug Policy, vol. 49, pp. 41 - 47, http://dx.doi.org/10.1016/j.drugpo.2017.07.029

Lancaster K; Seear K; Ritter A, 2017, 'Making medicine; producing pleasure: A critical examination of medicinal cannabis policy and law in Victoria, Australia', International Journal of Drug Policy, vol. 49, pp. 117 - 125, http://dx.doi.org/10.1016/j.drugpo.2017.07.020

Bright D; Greenhill C; Britz T; Ritter A; Morselli C, 2017, 'Criminal network vulnerabilities and adaptations', Global Crime, vol. 18, pp. 424 - 441, http://dx.doi.org/10.1080/17440572.2017.1377614

Lancaster K; Hughes C; Ritter A, 2017, '‘Drug dogs unleashed’: An historical and political account of drug detection dogs for street-level policing of illicit drugs in New South Wales, Australia', Australian and New Zealand Journal of Criminology, vol. 50, pp. 360 - 378, http://dx.doi.org/10.1177/0004865816642826

Lancaster K; Treloar C; Ritter A, 2017, '‘Naloxone works’: The politics of knowledge in ‘evidence-based’ drug policy', Health (United Kingdom), vol. 21, pp. 278 - 294, http://dx.doi.org/10.1177/1363459316688520

Hughes CE; Ritter A; Lancaster K; Hoppe R, 2017, 'Understanding policy persistence – the case of police drug detection dog policy in NSW, Australia', International Journal of Drug Policy, vol. 44, pp. 58 - 68, http://dx.doi.org/10.1016/j.drugpo.2017.03.007

Ritter A; Sotade O, 2017, 'Explaining the declining rates of past year cannabis use in Australia: A first pass', Drug and Alcohol Review, vol. 36, pp. 602 - 608, http://dx.doi.org/10.1111/dar.12553

Hughes CE; Moxham-Hall V; Ritter A; Weatherburn D; MacCoun R, 2017, 'The deterrent effects of Australian street-level drug law enforcement on illicit drug offending at outdoor music festivals', International Journal of Drug Policy, vol. 41, pp. 91 - 100, http://dx.doi.org/10.1016/j.drugpo.2016.12.018

Ritter A; Stevens A, 2017, 'Improving knowledge on law enforcement in drug policy', International Journal of Drug Policy, vol. 41, pp. 89 - 90, http://dx.doi.org/10.1016/j.drugpo.2017.02.001

Lancaster K; Seear K; Treloar C; Ritter A, 2017, 'The productive techniques and constitutive effects of ‘evidence-based policy’ and ‘consumer participation’ discourses in health policy processes', Social Science and Medicine, vol. 176, pp. 60 - 68, http://dx.doi.org/10.1016/j.socscimed.2017.01.031

Moxham-Hall VL; Ritter A, 2017, 'Indexes as a Metric for Drug and Alcohol Policy Evaluation and Assessment', World Medical and Health Policy, vol. 9, pp. 103 - 126, http://dx.doi.org/10.1002/wmh3.218

Belackova V; Ritter A; Shanahan M; Hughes CE, 2017, 'Assessing the concordance between illicit drug laws on the books and drug law enforcement: Comparison of three states on the continuum from “decriminalised” to “punitive”', International Journal of Drug Policy, vol. 41, pp. 148 - 157, http://dx.doi.org/10.1016/j.drugpo.2016.12.013

Vuong T; Nguyen N; Le G; Shanahan M; Ali R; Ritter A, 2017, 'The political and scientific challenges in evaluating compulsory drug treatment centers in Southeast Asia', Harm Reduction Journal, vol. 14, http://dx.doi.org/10.1186/s12954-016-0130-1

Barratt MJ; Ritter A, 2017, 'Commentary on Vrolijk et al. (2017): The paradox of the quality control problem', Addiction, vol. 112, pp. 101 - 102, http://dx.doi.org/10.1111/add.13611

Ritter A; Hoang VP; Cao VL; Shanahan M; Shukla N; Perez P; Farrell M, 2017, 'Modelling heroin careers over 40 years: Social costs', Drug and Alcohol Dependence, vol. 171, pp. e177 - e177, http://dx.doi.org/10.1016/j.drugalcdep.2016.08.486

Chalmers J; Ritter A; Berends L, 2016, 'Estimating met demand for alcohol and other drug treatment in Australia', Addiction, vol. 111, pp. 2041 - 2049, http://dx.doi.org/10.1111/add.13473

Ritter A; Hull P; Berends L; Chalmers J; Lancaster K, 2016, 'A conceptual schema for government purchasing arrangements for Australian alcohol and other drug treatment', Addictive Behaviors, vol. 60, pp. 228 - 234, http://dx.doi.org/10.1016/j.addbeh.2016.04.017

Berends L; Ritter A; Chalmers J, 2016, 'Collaborative Governance in the Reform of Western Australia's Alcohol and Other Drug Sector', Australian Journal of Public Administration, vol. 75, pp. 137 - 148, http://dx.doi.org/10.1111/1467-8500.12154

Chalmers J; Ritter A; Berends L; Lancaster K, 2016, 'Following the money: Mapping the sources and funding flows of alcohol and other drug treatment in Australia', Drug and Alcohol Review, vol. 35, pp. 255 - 262, http://dx.doi.org/10.1111/dar.12337

Ritter A; Livingston M; Chalmers J; Berends L; Reuter P, 2016, 'Comparative policy analysis for alcohol and drugs: Current state of the field', International Journal of Drug Policy, vol. 31, pp. 39 - 50, http://dx.doi.org/10.1016/j.drugpo.2016.02.004

Lancaster K; Ritter A, 2016, 'Erratum: Corrigendum to “Examining the construction and representation of drugs as a policy problem in Australia's National Drug Strategy documents 1985–2010” (International Journal of Drug Policy (2014) 25(1) (81–87) (S0955395913001175) (10.1016/j.drugpo.2013.07.002))', International Journal of Drug Policy, vol. 31, pp. 205, http://dx.doi.org/10.1016/j.drugpo.2016.02.017

Rhodes T; Stevens A; Ritter A; Decorte T, 2016, 'Advancing the science, methods and practices of drug policy research', International Journal of Drug Policy, vol. 31, pp. 1 - 3, http://dx.doi.org/10.1016/j.drugpo.2016.04.010

Ritter A; Berends L, 2016, 'Twenty years of (non)reform in Victorian alcohol and other drug treatment policy', Drug and Alcohol Review, vol. 35, pp. 250 - 254, http://dx.doi.org/10.1111/dar.12374

Hoang VP; Shanahan M; Shukla N; Perez P; Farrell M; Ritter A, 2016, 'A systematic review of modelling approaches in economic evaluations of health interventions for drug and alcohol problems', BMC Health Services Research, vol. 16, http://dx.doi.org/10.1186/s12913-016-1368-8

Ritter A; Stoove M, 2016, 'Alcohol and other drug treatment policy in australia', Medical Journal of Australia, vol. 204, pp. 138 - 138.e1, http://dx.doi.org/10.5694/mja15.01372

Ritter A, 2016, 'Impact of addictive substances and behaviours on individual and societal well-being', Drug and Alcohol Review, vol. 35, pp. 118 - 119, http://dx.doi.org/10.1111/dar.12334

Hoang PV; Shukla N; Cao VL; Shanahan M; Ritter A; Perez P, 2016, 'Individual-level simulation model for cost benefit analysis in healthcare', Proceedings 30th European Conference on Modelling and Simulation, pp. 1 - 7, http://simulation.su/uploads/files/default/2016-shukla-vu-van-shanahan-ritter-perez.pdf

Vuong T; Shanahan M; Nguyen N; Le G; Ali R; Pham K; Dinh T; Ritter A, 2016, 'Cost-effectiveness of center-based compulsory rehabilitation compared to community-based voluntary methadone maintenance treatment in Hai Phong City, Vietnam', Drug and Alcohol Dependence, vol. 168, pp. 147 - 155, http://dx.doi.org/10.1016/j.drugalcdep.2016.09.008

Ritter A; Schukla N; Shanahan M; Hoang P; Cao L; Perez P; Farrell M, 2016, 'Building a Microsimulation Model of Heroin Use Careers in Australia', The International Journal of Microsimulation, vol. 9, pp. 140 - 176, http://www.microsimulation.org/IJM/V9_3/6_IJM_2016_21_Ritter_edit_final.pdf

Lancaster K; Ritter A; Hughes C; Hoppe R, 2016, 'A critical examination of the introduction of drug detection dogs for policing of illicit drugs in New South Wales, Australia using Kingdon’s ‘multiple streams’ heuristic', Evidence & Policy: A Journal of Research, Debate and Practice, vol. 13, pp. 583 - 603, http://dx.doi.org/10.1332/174426416X14683497019265

Ritter A, 2016, 'Chasing the scream: The first and last days of the war on drugs Johann Hari London, United Kingdom: PB - Bloomsbury Circus, 2015 ISBN 978-1-4088-5784-7 389 pp. Paperback. Price: $29.99: Critique', Drug and Alcohol Review, vol. 35, pp. 650 - 650, http://dx.doi.org/10.1111/dar.12429

Ritter A, 2015, 'The privileged role of researchers in “evidence-based” policy: implications and engagement of other voices', Drugs and Alcohol Today, vol. 15, pp. 181 - 191, http://dx.doi.org/10.1108/DAT-06-2015-0027

Scott N; Caulkins JP; Ritter A; Dietze P, 2015, 'Patterns of drug preference and use among people who inject drugs in Melbourne, Australia', Addiction Research and Theory, vol. 23, pp. 459 - 468, http://dx.doi.org/10.3109/16066359.2015.1031118

Bright DA; Greenhill C; Reynolds M; Ritter A; Morselli C, 2015, 'The Use of Actor-Level Attributes and Centrality Measures to Identify Key Actors: A Case Study of an Australian Drug Trafficking Network', Journal of Contemporary Criminal Justice, vol. 31, pp. 262 - 278, http://dx.doi.org/10.1177/1043986214553378

Bright DA; Greenhill C; Ritter A; Morselli C, 2015, 'Networks within networks: using multiple link types to examine network structure and identify key actors in a drug trafficking operation', Global Crime, vol. 16, pp. 219 - 237, http://dx.doi.org/10.1080/17440572.2015.1039164

Lancaster K; Duke K; Ritter A, 2015, 'Producing the 'problem of drugs': A cross national-comparison of 'recovery' discourse in two Australian and British reports', International Journal of Drug Policy, vol. 26, pp. 617 - 625, http://dx.doi.org/10.1016/j.drugpo.2015.04.006

Ritter A; Chalmers J; Berends L, 2015, 'Health expenditure on alcohol and other drug treatment in Australia (2012/2013)', Drug and Alcohol Review, vol. 34, pp. 397 - 403, http://dx.doi.org/10.1111/dar.12248

Ritter A, 2015, 'New Australian lesbian, gay, bisexual and transgender research-and the need for more', Drug and Alcohol Review, vol. 34, pp. 347 - 348, http://dx.doi.org/10.1111/dar.12291

Lancaster K; Santana L; Madden A; Ritter A, 2015, 'Stigma and subjectivities: Examining the textured relationship between lived experience and opinions about drug policy among people who inject drugs', Drugs: Education, Prevention and Policy, vol. 22, pp. 224 - 231, http://dx.doi.org/10.3109/09687637.2014.970516

McSweeney T; Hughes CE; Ritter A, 2015, 'Tackling 'drug-related' crime: Are there merits in diverting drug-misusing defendants to treatment? Findings from an Australian case study', Australian & New Zealand Journal of Criminology, vol. 49, pp. 198 - 220, http://dx.doi.org/10.1177/0004865814555773

Scott N; Caulkins JP; Ritter A; Quinn C; Dietze P, 2015, 'High-frequency drug purity and price series as tools for explaining drug trends and harms in Victoria, Australia', Addiction, vol. 110, pp. 120 - 128, http://dx.doi.org/10.1111/add.12740

Ritter A; Scott N; Caulkins JP; Dietze P, 2015, 'How patterns of injecting drug use evolve in a cohort of people who inject drugs', Trends & issues in crime and criminal justice, vol. 502, pp. 1 - 7, http://aic.gov.au/media_library/publications/tandi_pdf/tandi502.pdf

Hughes CE; Cowdery N; Ritter A, 2015, 'Deemed Supply in Australian Drug Trafficking Laws: A Justifiable Legal Provision?', Current Issues in Criminal Justice, vol. 27, pp. 1 - 20, http://search.informit.com.au/documentSummary;dn=366887334489689;res=IELHSS

Hughes CE; Ritter A; Cowdery N; Sindicich N, 2014, ''Trafficking' or 'personal use': Do people who regularly inject drugs understand Australian drug trafficking laws?', Drug and Alcohol Review, vol. 33, pp. 658 - 666, http://dx.doi.org/10.1111/dar.12167

Ritter A; Stenius K, 2014, 'Celebrating Robin Room', Drug and Alcohol Review, vol. 33, pp. 575 - 576, http://dx.doi.org/10.1111/dar.12220

Shanahan M; Ritter A, 2014, 'Cost benefit analysis of two policy options for cannabis: Status quo and legalisation', PLoS ONE, vol. 9, http://dx.doi.org/10.1371/journal.pone.0095569

Lancaster K; Sutherland R; Ritter A, 2014, 'Examining the opinions of people who use drugs towards drug policy in Australia', Drugs: Education, Prevention and Policy, vol. 21, pp. 93 - 101, http://dx.doi.org/10.3109/09687637.2013.838211

Lancaster K; Ritter A; Colebatch H, 2014, 'Problems, policy and politics: making sense of Australia's ‘ice epidemic’', Policy Studies, vol. 35, pp. 147 - 171, http://dx.doi.org/10.1080/01442872.2013.875144

Lancaster K; Ritter A, 2014, 'Making change happen: A case study of the successful establishment of a peer-administered naloxone program in one Australian jurisdiction', International Journal of Drug Policy, vol. 25, pp. 985 - 991, http://dx.doi.org/10.1016/j.drugpo.2014.02.003

Hughes C; Ritter A; Cowdery N; Phillips B, 2014, 'Australian threshold quantities for 'drug trafficking': Are they placing drug users at risk of unjustified sanction?', Trends and Issues in Crime and Criminal Justice, pp. 1 - 7

Hughes CE; Ritter A; Cowdery N, 2014, 'Legislating thresholds for drug trafficking: A policy development case study from New South Wales, Australia', International Journal of Drug Policy, vol. 25, pp. 992 - 1000, http://dx.doi.org/10.1016/j.drugpo.2014.03.002

Matthew-Simmons F; Ritter A, 2014, ''Miracle cure' or 'liquid handcuffs': Reporting on naltrexone and methadone in the Australian print media', Drug and Alcohol Review, vol. 33, pp. 506 - 514, http://dx.doi.org/10.1111/dar.12134

Shanahan M; Gerard K; Ritter A, 2014, 'Preferences for policy options for cannabis in an Australian general population: A discrete choice experiment', International Journal of Drug Policy, vol. 25, pp. 682 - 690, http://dx.doi.org/10.1016/j.drugpo.2014.03.005

Ritter A, 2014, 'Where is the pleasure?', Addiction, vol. 109, pp. 1587 - 1588, http://dx.doi.org/10.1111/add.12545

Ritter A, 2013, 'The Drug Problem in the Americas Organization of American States', DRUG AND ALCOHOL REVIEW, vol. 32, pp. 636 - 637, http://dx.doi.org/10.1111/dar.12064

Vuong T; Ritter A, 2013, 'Not to lose sight of the bigger picture: the case of therapeutic communities (TC) research in closed settings in Thailand.', Substance use & misuse, vol. 48, pp. 793 - 794

Lancaster K; Ritter A; Stafford J, 2013, 'Public opinion and drug policy in Australia: Engaging the ‘affected community’', Drug and Alcohol Review, vol. 32, pp. 60 - 66, http://dx.doi.org/10.1111/j.1465-3362.2012.00497.x

Hughes CE; Ritter A; Mabbitt N, 2013, 'Drug policy coordination: Identifying and assessing dimensions of coordination', International Journal of Drug Policy, vol. 24, pp. 244 - 250, http://dx.doi.org/10.1016/j.drugpo.2012.08.004

Lancaster K; Ritter A, 2013, 'Examining the construction and representation of drugs as a policy problem in Australia's National Drug Strategy documents 1985¿2010', International Journal of Drug Policy, vol. 25, pp. 81 - 87, http://dx.doi.org/10.1016/j.drugpo.2013.07.002

Vuong T; Ritter A, 2013, 'Not to Lose Sight of the Bigger Picture: The Case of Therapeutic Communities (TC) Research in Closed Settings in Thailand', Substance Use and Misuse, vol. 48, pp. 793 - 794, http://dx.doi.org/10.3109/10826084.2013.791320

Matthew-Simmons F; Sunderland M; Ritter A, 2013, 'Exploring the existence of drug policy ‘ideologies’ in Australia', Drugs - Education Prevention and Policy, vol. 20, pp. 258 - 267, http://dx.doi.org/10.3109/09687637.2012.755494

Shanahan MD; Ritter A, 2013, 'Confronting the challenges of conducting a CBA of cannabis policies', Drugs - Education Prevention and Policy, vol. 20, pp. 175 - 183, http://dx.doi.org/10.3109/09687637.2013.763906

Stevens A; Ritter A, 2013, 'How can and do empirical studies influence drug policies? Narratives and complexity in the use of evidence in policy making', Drugs - Education Prevention and Policy, vol. 20, pp. 169 - 174, http://dx.doi.org/10.3109/09687637.2013.793892

Shanahan MD; Ritter A, 2013, 'Intangible outcomes from a policy change: using contingent valuation to quantify potential stigma from a cannabis offence', Journal of Experimental Criminology, vol. Advance online publication, pp. 1 - 19, http://dx.doi.org/10.1007/s11292-013-9176-1/fulltext.html

Lancaster K; Ritter A; Stafford J, 2013, 'Public opinion and drug policy in Australia: Engaging the 'affected community'', Drug and Alcohol Review, vol. 32, pp. 60 - 66, http://dx.doi.org/10.1111/j.1465-3362.2012.00497.x

Ritter A; Lancaster K, 2013, 'Measuring research influence on drug policy: A case example of two epidemiological monitoring systems', International Journal of Drug Policy, vol. 24, pp. 30 - 37, http://dx.doi.org/10.1016/j.drugpo.2012.02.005

Ritter A; Lancaster K, 2013, 'Illicit drugs, policing and the evidence-based policy paradigm', Evidence and Policy A Journal of Research Debate and Practice, vol. 9, pp. 457 - 472, http://dx.doi.org/10.1332/174426413X662662

Lancaster K; Hughes CE; Chalmers J; Ritter A, 2012, 'More than problem-solving: Critical reflections on the 'problematisation' of alcohol-related violence in Kings Cross', Drug and Alcohol Review, vol. 31, pp. 925 - 927, http://dx.doi.org/10.1111/j.1465-3362.2012.00516.x

Hughes C; Phillips B; Ritter A; Cowdery N, 2012, ''TRAFFICKING' OR 'PERSONAL USE': DO REGULAR DRUG USERS UNDERSTAND AUSTRALIAN DRUG TRAFFICKING LAWS?', DRUG AND ALCOHOL REVIEW, vol. 31, pp. 53 - 53, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000311236700163&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Lancaster K; Ritter A, 2012, 'A CONSERVATIVE SHIFT IN DRUG POLICY (?): EVIDENCE AND IMPLICATIONS', DRUG AND ALCOHOL REVIEW, vol. 31, pp. 19 - 19, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000311236700061&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Ritter A, 2012, 'UNRAVELLING DRUG POLICY: MANY THREADS', DRUG AND ALCOHOL REVIEW, vol. 31, pp. 73 - 73, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000311236700225&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Ritter A; Matthew-Simmons F; Carragher N, 2012, 'Why the alcohol and other drug community should support gay marriage', Drug and Alcohol Review, vol. 31, pp. 1 - 3, http://dx.doi.org/10.1111/j.1465-3362.2011.00410.x

Ritter A; Matthew-Simmons F; Carragher N, 2012, 'Why the alcohol and other drug community should support gay marriage: Editorial', Drug and Alcohol Review, vol. 31, pp. 1 - 3, http://dx.doi.org/10.1111/j.1465-3362.2011.00410.x/pdf

Ritter A; Matthew-Simmons F, 2012, 'What does the research evidence tell us about what Australians think about the legal status of drugs?', DPMP Bulletin Series, vol. 21, pp. 1 - 2, http://www.dpmp.unsw.edu.au/DPMPWeb.nsf/resources/BULLETIN5/$file/DPMP+Bulletin+21.pdf

Lancaster K; Hughes CE; Chalmers JJ; Ritter A, 2012, 'More than problem-solving: Critical reflections on the ‘problematisation’ of alcohol-related violence in Kings Cross', Drug and Alcohol Review, vol. 31, pp. 925 - 927, http://dx.doi.org/10.1111/j.1465-3362.2012.00516.x/full

Frewen A; Molan J; Ritter A; Bell J, 2012, 'A new approach to developing clinically-based guidelines: the experience of developing guidelines for management of drug dependent women and neonates and for cannabis dependence', International Journal of Person-Centered Medicine, vol. 2, pp. 870 - 877, http://www.ijpcm.org/index.php/IJPCM/article/view/300

Ritter A, 2012, 'Alison Ritter on Friedman et al.'s "Has United States drug policy failed? And how could we know?"Policy as structured interaction, engaging multiple voices', Substance Use and Misuse, vol. 47, pp. 1406 - 1407, http://dx.doi.org/10.3109/10826084.2012.723555

Chalmers JJ; Ritter A, 2012, 'Subsidising patient dispensing fees: The cost of injecting equity into the opioid pharmacotherapy maintenance system', Drug and Alcohol Review, vol. 31, pp. 911 - 917, http://dx.doi.org/10.1111/j.1465-3362.2012.00472.x

Gong W; Ritter A; Bright DA; Doran CM, 2012, 'How profitable is methamphetamine dealing in Australia?', Drug and Alcohol Dependence, vol. 122, pp. 208 - 212, http://dx.doi.org/10.1016/j.drugalcdep.2011.09.028

Buykx P; Ritter A; Loxley W; Dietze P, 2012, 'Patients who attend the emergency department following medication overdose: Self-reported mental health history and intended outcomes of overdose', International Journal of Mental Health and Addiction, vol. 10, pp. 501 - 511, http://dx.doi.org/10.1007/s11469-011-9338-1

Ritter A, 2011, 'Is quantity more important than quality?', Addiction, vol. 106, pp. 2067 - 2068, http://dx.doi.org/10.1111/j.1360-0443.2011.03504.x

Lancaster K; Ritter A, 2011, 'PUBLIC OPINION AND DRUG POLICY: ENGAGING THE 'AFFECTED COMMUNITY'', DRUG AND ALCOHOL REVIEW, vol. 30, pp. 52 - 52, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000297019700158&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Ritter A, 2011, 'PRESENTATION 4-TRANSLATING RESEARCH FINDINGS IN THE AREA OF INJECTING DRUG USE', DRUG AND ALCOHOL REVIEW, vol. 30, pp. 27 - 27, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000297019700080&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Matthew-Simmons F; Shanahan M; Ritter A, 2011, 'Reported value of cannabis seizures in Australian newspapers: Are they accurate?', Drug and Alcohol Review, vol. 30, pp. 21 - 25, http://dx.doi.org/10.1111/j.1465-3362.2010.00189.x

Ritter A; Chalmers J, 2011, 'The relationship between economic conditions and substance use and harm', Drug and Alcohol Review, vol. 30, pp. 1 - 3, http://dx.doi.org/10.1111/j.1465-3362.2010.00282.x

Ritter A; Chalmers JJ, 2011, 'The relationship between economic conditions and substance use and harm', Drug and Alcohol Review, vol. 30, pp. 1 - 3, http://dx.doi.org/10.1111/j.1465-3362.2010.00282.x/full

Ritter A, 2011, 'Is quantity more important than quality? Commentary on Humphreys and McLellan (2011)', Addiction, vol. 106, pp. 2067 - 2068, http://dx.doi.org/10.1111/j.1360-0443.2011.03504.x/full

Ritter A, 2011, 'The role of research evidence in drug policy development in Australia', Politicka misao, vol. 48, pp. 141-156, http://hrcak.srce.hr/index.php?show=clanak&id_clanak_jezik=119724

Bright DA; Ritter A, 2011, 'Australian trends in drug user and drug dealer arrest rates: 1993 to 2006-07', Psychiatry, Psychology and Law, vol. 18, pp. 190 - 201, http://dx.doi.org/10.1080/13218711003739524

Murray JM; Ritter A, 2011, 'Findings regarding reduced prevalence with hepatitis C treatment are still valid: a reply to Vickerman et al', Drug and Alcohol Dependence, vol. 113, pp. 86 - 87, http://dx.doi.org/10.1016/j.drugalcdep.2010.08.002

Chalmers JJ; Ritter A, 2011, 'The business cycle and drug use in Australia: Evidence from repeated cross-sections of individual level data', International Journal of Drug Policy, vol. 22, pp. 341 - 352, http://dx.doi.org/10.1016/j.drugpo.2011.03.006

Ritter A, 2011, 'Ensuring the policy relevance of population health research: experiences from the Drug Policy Modelling Program', NSW Public Health Bulletin, vol. 22, pp. 19 - 22, http://dx.doi.org/10.1071/NB10062

Lee N; Jenner L; Baker AL; Ritter A; Hides L; Norman J; Kay-Lambkin F; Hall K; Dann F; Cameron J, 2011, 'Screening and intervention for mental health problems in alcohol and other drug settings: Can training change practitioner behaviour?', Drugs - Education Prevention and Policy, vol. 18, pp. 157 - 160, http://dx.doi.org/10.3109/09687631003727847

Matthew-Simmons F; Shanahan MD; Ritter A, 2011, 'Reported value of cannabis seizures in Australian newspapers: are they accurate?', Drug and Alcohol Review, vol. 30, pp. 21 - 25, http://dx.doi.org/10.1111/j.1465-3362.2010.00189.x

Dunlop A; Ritter A; Templeman D; Berends L; Linzteris N, 2010, 'SYMPOSIUM - NATIONAL HOSPITALS AND HEALTHCARE REFORM AND DRUG AND ALCOHOL TREATMENT: THE GREAT LEAP FORWARD OR STUCK IN THE BACKBLOCKS?', DRUG AND ALCOHOL REVIEW, vol. 29, pp. 23 - 24, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000284895600054&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Matthew-simmons F; Shanahan MD; Ritter A, 2010, 'Estimating the street value of a cannabis plant in Australia', DPMP Bulletin Series, vol. 19, pp. 1 - 2, http://www.dpmp.unsw.edu.au/DPMPWeb.nsf/resources/BULLETIN4/$file/DPMP+Bulletin+19.pdf

Bright DA; Ritter A, 2010, 'Retail price as an outcome measure for the effectiveness of drug law enforcement', International Journal of Drug Policy, vol. 21, pp. 359 - 363, http://dx.doi.org/10.1016/j.drugpo.2009.12.001

Zeiler I; Langlands TA; Murray JM; Ritter A, 2010, 'Optimal targeting of Hepatitis C virus treatment among injecting drug users to those not enrolled in methadone maintenance programs', Drug and Alcohol Dependence, vol. 110, pp. 228 - 233, http://dx.doi.org/10.1016/j.drugalcdep.2010.03.006

Buykx P; Loxley W; Dietze P; Ritter A, 2010, 'Medications used in overdose and how they are acquired - an investigation of cases attending an inner Melbourne emergency department', Australian and New Zealand Journal of Public Health, vol. 34, pp. 401 - 404, http://dx.doi.org/10.1111/j.1753-6405.2010.00573.x

Ritter A; Bammer G, 2010, 'Models of policy-making and their relevance for drug research', Drug and Alcohol Review, vol. 29, pp. 352 - 357, http://dx.doi.org/10.1111/j.1465-3362.2009.00155.x

Ritter A, 2010, 'Illicit drugs policy through the lens of regulation', International Journal of Drug Policy, vol. 21, pp. 265 - 270, http://dx.doi.org/10.1016/j.drugpo.2009.11.002

Buykx P; Dietze P; Ritter A; Loxley W, 2010, 'Characteristics of medication overdose presentations to the ED: how do they differ from illicit drug overdose and self-harm cases?', Emergency Medicine Journal, vol. 27, pp. 499 - 503, http://dx.doi.org/10.1136/emj.2009.075549

Ritter A, 2010, 'Conceptualising 'balance' in national drug policy', Drug and Alcohol Review, vol. 29, pp. 349 - 351, http://dx.doi.org/10.1111/j.1465-3362.2010.00210.x

Bright DA; Ritter A, 2009, 'A CONCEPTUAL FRAMEWORK FOR ILLICIT DRUG SEIZURES: WHAT DO SEIZURES REALLY MEAN?', DRUG AND ALCOHOL REVIEW, vol. 28, pp. A5 - A6, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000270916300018&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Grech K; Gong W; Ritter A, 2009, 'ESTIMATING GOVERNMENT DRUG POLICY EXPENDITURE IN AUSTRALIA', DRUG AND ALCOHOL REVIEW, vol. 28, pp. A25 - A25, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000270916300078&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Gong W; Ritter A; Bright DA; Doran C, 2009, 'REVIEW OF ECONOMIC EVALUATION METHODS OF LAW ENFORCEMENT AGAINST DRUGS', DRUG AND ALCOHOL REVIEW, vol. 28, pp. A25 - A25, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000270916300076&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Matthew-Simmons F; Shanahan M; Ritter A, 2009, 'REPORTED VALUE OF CANNABIS SEIZURES IN AUSTRALIAN NEWSPAPERS: ARE THEY ACCURATE?', DRUG AND ALCOHOL REVIEW, vol. 28, pp. A42 - A42, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000270916300126&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Ritter A, 2009, 'INTERNATIONAL DRUG CONTROL INTO THE 21ST CENTURY', HEALTH SOCIOLOGY REVIEW, vol. 18, pp. 341 - 342, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000272751300015&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Ritter A, 2009, 'Methods for comparing drug policies-The utility of composite Drug Harm Indexes', International Journal of Drug Policy, vol. 20, pp. 475 - 479, http://dx.doi.org/10.1016/j.drugpo.2009.02.012

Ritter A, 2009, 'How do drug policy makers access research evidence?', International Journal of Drug Policy, vol. 20, pp. 70 - 75, http://dx.doi.org/10.1016/j.drugpo.2007.11.017

Bammer G; Ritter A; Kutin JJ; Lintzeris N, 2009, 'Fast-tracking implementation through trial design: the case of buprenorphine treatment in Victoria', Australian and New Zealand Journal of Public Health, vol. 33, pp. 34 - 39, http://dx.doi.org/10.1111/j.1753-6405.2009.00335.x

Dray A; Mazerolle L; Perez P; Ritter A, 2008, 'Policing Australia’s heroin drought: using an agent-based model to simulate alternative outcomes', Journal of Experimental Criminology, vol. 4, pp. 267 - 288, http://dx.doi.org/10.1007/s11292-008-9057-1

Ritter A, 2008, 'Speaking truth to power', Drug and Alcohol Review, vol. 27, pp. 113 - 114, http://dx.doi.org/10.1080/09595230701858453

Ritter A; McDonald D, 2008, 'Illicit drug policy: Scoping the interventions and taxonomies', Drugs - Education Prevention and Policy, vol. 15, pp. 15 - 35, http://dx.doi.org/10.1080/09687630701204344

Ritter A; Clemens S, 2008, 'Estimating the prevalence of individuals likely to use publicly funded alcohol treatment services: an indirect estimation technique', Drug and Alcohol Review, vol. 27, pp. 504 - 508, http://dx.doi.org/10.1080/09595230802093752

Ritter A, 2007, 'LIVING WITH DRUGS', HEALTH SOCIOLOGY REVIEW, vol. 16, pp. 351 - 352, http://dx.doi.org/10.5172/hesr.2007.16.3-4.351

Caulkins JP; Dietze P; Ritter A, 2007, 'Dynamic compartmental model of trends in Australian drug use', Health Care Management Science, vol. 10, pp. 151 - 162, http://dx.doi.org/10.1007/s10729-007-9012-0

Ritter A, 2007, 'Methamphetamine alarm: Are we forgetting what we know?', Drug and Alcohol Review, vol. 26, pp. 227 - 230, http://dx.doi.org/10.1080/09595230701255817

Cameron J; Ritter A, 2007, 'Contingency management: Perspectives of Australian service providers', Drug and Alcohol Review, vol. 26, pp. 183 - 189, http://dx.doi.org/10.1080/09595230601184653

Winstock A; Lea T; Ritter A, 2007, 'The impact of community pharmacy dispensing fees on the introduction of buprenorphine - naloxone in Australia', Drug and Alcohol Review, vol. 26, pp. 411 - 416, http://dx.doi.org/10.1080/09595230701373891

Moore TJ; Ritter A; Caulkins J, 2007, 'The costs and consequences of three policy options for reducing heroin dependency', Drug and Alcohol Review, vol. 26, pp. 369 - 378, http://dx.doi.org/10.1080/09595230701373883

Ritter A; Bammer G; Hamilton M; Mazerolle L, 2007, 'Effective drug policy: a new approach demonstrated in the Drug Policy Modelling Program', Drug and Alcohol Review, vol. 26, pp. 265 - 271, http://dx.doi.org/10.1080/09595230701247665

Ritter A, 2007, 'Comparing alcohol policies between countries: Science or silliness?', PLOS Medicine, vol. 4, pp. 616 - 618, http://dx.doi.org/10.1371/journal.pmed.0040153

Ritter A; Cameron J, 2007, 'Australian clinician attitudes towards contingency management: Comparing down under with America', Drug and Alcohol Dependence, vol. 87, pp. 312 - 315, http://dx.doi.org/10.1016/j.drugalcdep.2006.08.011

Fry CL; Hall W; Ritter A; Jenkinson R, 2006, 'The ethics of paying drug users who participate in research: A review and practical recommendations', JOURNAL OF EMPIRICAL RESEARCH ON HUMAN RESEARCH ETHICS, vol. 1, pp. 21 - 35, http://dx.doi.org/10.1525/jer.2006.1.4.21

Ritter A; Cameron J, 2006, 'A review of the efficacy and effectiveness of harm reduction strategies for alcohol, tobacco and illicit drugs', Drug and Alcohol Review, vol. 25, pp. 611 - 624, http://dx.doi.org/10.1080/09595230600944529

Ritter A, 2006, 'Drug and Alcohol Review: Editorial', Drug and Alcohol Review, vol. 25, pp. 391 - 392, http://dx.doi.org/10.1080/09595230600919471

Ritter A, 2006, 'Studying illicit drug markets: Disciplinary contributions', International Journal of Drug Policy, vol. 17, pp. 453 - 463

Ross JE; Teesson M; Darke S; Lynskey MT; Ali RL; Ritter A; Cooke R, 2006, 'Short-term Outcomes for the Treatment of Heroin Dependence: Findings From the Australian Treatment Outcome Study (ATOS)', Addictive Disorders and their Treatment, vol. 5, pp. 133 - 143, http://dx.doi.org/10.1097/01.adt.0000210717.33564.a8

Teesson M; Ross JE; Darke S; Lynskey M; Ali RL; Ritter A, 2006, 'One year outcomes for heroin dependence: Findings from the Australian Treatment Outcome Study (ATOS)', Drug and Alcohol Dependence, vol. 83, pp. 174 - 180, http://dx.doi.org/10.1016/j.drugalcdep.2005.11.009

O Brien SM; Mattick RP; White J; Breen CL; Kimber J; Ritter A; Lintzeris N, 2006, 'Maintenance Pharmacotherapy for Opioid Dependence and SR-36 Health Status: A Comparison with General Population Norms and Other Chronic Disorders', Addictive Disorders and Their Treatment, vol. 5, pp. 155 - 164, http://dx.doi.org/10.1097/01.adt.0000210078.99735.27

Digiusto EA; Shakeshaft AP; Ritter A; Mattick RP; White J; Lintzeris N; Bell JR; Saunders J, 2006, 'Effects of pharmacotherapies for opioid dependence on participants` criminal behaviour and expenditure on illicit drugs: An Australian National Evaluation (NEPOD)', Australian and New Zealand Journal of Criminology, vol. 39, pp. 171 - 189, http://dx.doi.org/10.1375/acri.39.2.171

Ritter A, 2006, 'Study illicit drug markets: Disciplinary contributions', International Journal of Drug Policy, vol. 17, pp. 453 - 463, http://dx.doi.org/10.1016/j.drugpo.2006.09.004

Fry CL; Ritter A; Bowen KJ; Gardiner P; Holt T; Jenkinson R; Johnston J; Baldwin S, 2005, 'Paying research participants: A study of current practices in Australia', Journal of Medical Ethics, vol. 31, pp. 542 - 547, http://dx.doi.org/10.1136/jme.2004.009290

Ritter A; Natale RDI, 2005, 'The relationship between take-away methadone policies and methadone diversion', Drug and Alcohol Review, vol. 24, pp. 347 - 352, http://dx.doi.org/10.1080/09595230500263939

Harris AH; Gospodarevskaya E; Ritter AJ, 2005, 'A randomised trial of the cost effectiveness of buprenorphine as an alternative to methadone maintenance treatment for heroin dependence in a primary care setting', PharmacoEconomics, vol. 23, pp. 77 - 91, http://dx.doi.org/10.2165/00019053-200523010-00007

Caldicott DGE; Duff C; Ritter AJ; Wodak AD; Crofts JN, 2005, 'Reducing drug-related harm: Australia leads the way (multiple letters) [6]', Medical Journal of Australia, vol. 182, pp. 140 - 141, http://dx.doi.org/10.5694/j.1326-5377.2005.tb06624.x

Ritter AJ; Wodak AD; Crofts JN, 2005, 'Reducing drug-related harm: Australia leads the way - Reply', MEDICAL JOURNAL OF AUSTRALIA, vol. 182, pp. 141 - 141, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000227346100023&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Digiusto E; Shakeshaft A; Ritter A; O'Brien S; Mattick RP, 2005, 'Erratum: Serious adverse events in the Australian National Evaluation of Pharmacotherapies for Opioid Dependence (NEPOD) (Addiction (2004) 99 (450-460))', Addiction, vol. 100, pp. 139, http://dx.doi.org/10.1111/j.1360-0443.2004.01004.x

Ross JE; Teesson M; Darke S; Lynskey MT; Ali RL; Ritter A; Cooke R, 2005, 'The characteristics of heroin users entering treatment: findings from the Australian Treatment Outcome Study (ATOS)', Drug and Alcohol Review, vol. 24, pp. 411 - 418, http://dx.doi.org/10.1080/09595230500286039

Darke S; Ross JE; Teesson M; Ali RL; Cooke R; Ritter A; Lynskey M, 2005, 'Factors associated with 12 months continuous heroin abstinence: findings from the Australian Treatment Outcome Study (ATOS)', Journal of Substance Abuse Treatment, vol. 28, pp. 255 - 263, http://dx.doi.org/10.1016/j.jsat.2005.01.006

Ritter AJ; Wodak AD; Crofts JN, 2005, 'Reducing drug‐related harm: Australia leads the way', Medical Journal of Australia, vol. 182, pp. 140 - 141, http://dx.doi.org/10.5694/j.1326-5377.2005.tb06625.x

Tucker T; Ritter A; Maher C; Jackson H, 2004, 'A randomized control trial of group counseling in a naltrexone treatment program', Journal of Substance Abuse Treatment, vol. 27, pp. 277 - 288, http://dx.doi.org/10.1016/j.jsat.2004.08.003

Ritter AJ; Wodak AD; Crofts JN, 2004, 'Reducing drug-related harm: Australia leads the way', Medical Journal of Australia, vol. 181, pp. 242 - 243, http://dx.doi.org/10.5694/j.1326-5377.2004.tb06260.x

Tucker TK; Ritter AJ; Maher C; Jackson H, 2004, 'Naltrexone maintenance for heroin dependence: Uptake, attrition and retention', Drug and Alcohol Review, vol. 23, pp. 299 - 309, http://dx.doi.org/10.1080/09595230412331289464

Lintzeris N; Ritter A; Panjari M; Clark N; Kutin J; Bammer G, 2004, 'Implementing Buprenorphine Treatment in Community Settings in Australia: Experiences from the Buprenorphine Implementation Trial', American Journal on Addictions, vol. 13, http://dx.doi.org/10.1080/10550490490440799

Caplehorn J; Ritter A, 2004, 'Comments on Ritter et al.'s report of a comparative trial of laam and methadone maintenance [1] (multiple letters)', Addiction, vol. 99, pp. 509 - 510, http://dx.doi.org/10.1111/j.1360-0443.2004.00682.x

Digiusto EA; Shakeshaft AP; Ritter A; O Brien SM; Mattick RP, 2004, 'Serious adverse events in the Australian National Evaluation of Pharmacotherapies for Opioid Dependence (NEPOD)', Addiction, vol. 99, pp. 450 - 460, http://dx.doi.org/10.1111/j.1360-0443.2004.00654.x

Tucker T; Fry C; Lintzeris N; Baldwin S; Ritter A; Donath S; Whelan G, 2004, 'Randomized controlled trial of a brief behavioural intervention forreducing hepatitis C virus risk practices among injecting drug users', Addiction, vol. 99, pp. 1157 - 1166, http://dx.doi.org/10.1111/j.1360-0443.2004.00809.x

2004, 'LAAM vs. methadone: a response to Caplehorn', Addiction, vol. 99, pp. 510 - 511, http://dx.doi.org/10.1111/j.1360-0443.2004.00695.x

Ritter AJ; Lintzeris N; Clark N; Kutin JJ; Bammer G; Panjari M, 2003, 'A randomized trial comparing levo-alpha acetylmethadol with methadone maintenance for patients in primary care settings in Australia', Addiction, vol. 98, pp. 1605 - 1613, http://dx.doi.org/10.1046/j.1360-0443.2003.00529.x

Ritter AJ; Fry CL; Swan A, 2003, 'The ethics of reimbursing injecting drug users for public health research interviews: What price are we prepared to pay?', International Journal of Drug Policy, vol. 14, pp. 1 - 3, http://dx.doi.org/10.1016/S0955-3959(02)00094-4

Breen CL; Harris S; Lintzeris N; Mattick RP; Hawken L; Bell JR; Ritter A; Lenne M; Mendoza E, 2003, 'Cessation of methadone maintenance treatment using uprenorphine: transfer from methadone to buprenorphine and subsequent buprenorphine reductions', Drug and Alcohol Dependence, vol. 71, pp. 49 - 55, http://dx.doi.org/10.1016/S0376-8716(03)00071-1

Lintzeris N; Dunlop A; Muhleisen P; Ritter A, 2002, 'Training primary health care professionals to prvide Buprenorphine and LAAM treatment', Substance Abuse, vol. 23, pp. 245 - 254, http://dx.doi.org/10.1080/08897070209511497

Ritter A; Bowden S; Murray T; Ross P; Greeley J; Pead J, 2002, 'The influence of the therapeutic relationship in treatment for alcohol dependency', Drug and Alcohol Review, vol. 21, pp. 261 - 268, http://dx.doi.org/10.1080/0959523021000002723

Ritter AJ, 2002, 'Naltrexone in the treatment of heroin dependence: Relationship with depression and risk of overdose', Australian and New Zealand Journal of Psychiatry, vol. 36, pp. 224 - 228, http://dx.doi.org/10.1046/j.1440-1614.2002.01012.x

Wodak AD; Ritter AJ; Watson CRR; Hall WD; Mattick RP; Kimber J, 2002, 'Separating politics and scientific research on heroin prescription (multiple letters)', Medical Journal of Australia, vol. 176, pp. 449 - 450, http://dx.doi.org/10.5694/j.1326-5377.2002.tb04510.x

Clark N; Lintzeris N; Gijsbers A; Whelan G; Dunlop A; Ritter A; Ling W, 2002, 'LAAM maintenance vs methadone maintenance for heroin dependence.', Cochrane database of systematic reviews (Online)

Dunlop A; Higgs P; Jordens J; Ritter A; Bammer G; Whelan G; Maher L; Higgs P, 2002, 'Vietnamese-Australian heroin users; Ambulatory withdrawal and 24-month follow-up', Addiction Biology, vol. 7, pp. 335 - 335

Lintzeris N; Ritter A; Dunlop A; Muhleisen P, 2002, '', Substance Abuse, vol. 23, pp. 245 - 254, http://dx.doi.org/10.1023/a:1021102301285

Bowden SC; Ritter AJ; Carstairs JR; Shores EA; Pead J; Greeley JD; Whelan G; Long CM; Clifford CC, 2001, 'Factorial invariance for combined Wechsler Adult intelligence Scale-Revised and Wechsler Memory Scale-Revised scores in a sample of clients with alcohol dependency', Clinical Neuropsychologist, vol. 15, pp. 69 - 80, http://dx.doi.org/10.1076/clin.15.1.69.1910

Ritter A, 2001, 'Buprenorphine for the treatment of heroin dependence', DRUG AND ALCOHOL REVIEW, vol. 20, pp. 5 - 7, http://dx.doi.org/10.1080/0959523020035240

Lenne M; Lintzeris N; Breen CL; Harris S; Hawken L; Mattick RP; Ritter A, 2001, 'Withdrawal from methadone maintenance treatment: prognosis and participant perspectives', Australian and New Zealand Journal of Public Health, vol. 25, pp. 121 - 125, http://dx.doi.org/10.1111/j.1753-6405.2001.tb01832.x

Tucker TK; Ritter AJ, 2000, 'Naltrexone in the treatment of heroin dependence: A literature review', Drug and Alcohol Review, vol. 19, pp. 73 - 82, http://dx.doi.org/10.1080/09595230096174

Lintzeris N; Lenné M; Ritter A, 1999, 'Methadone injecting in Australia: A tale of two cities', Addiction, vol. 94, pp. 1175 - 1178, http://dx.doi.org/10.1046/j.1360-0443.1999.94811757.x

Ritter A; Lang E; Kutin J; King T; Dietze P, 1999, 'News and Views', Drug and Alcohol Review, vol. 18, pp. 117 - 122, http://dx.doi.org/10.1080/09595239996842

Bowden SC; Fowler KS; Bell RC; Whelan G; Clifford CC; Ritter AJ; Long CM, 1998, 'The reliability and internal validity of the Wisconsin Card Sorting Test', Neuropsychological Rehabilitation, vol. 8, pp. 243 - 254, http://dx.doi.org/10.1080/713755573

Bowden SC; Dodds B; Whelan G; Long C; Dudgeon P; Ritter A; Clifford C, 1997, 'Confirmatory factor analysis of the Wechsler Memory Scale-Revised in a sample of clients with alcohol dependency', Journal of Clinical and Experimental Neuropsychology, vol. 19, pp. 755 - 762, http://dx.doi.org/10.1080/01688639708403757

Bowden SC; Benedikt R; Ritter AJ, 1992, 'Delayed matching to sample and concurrent learning in nonamnesic humans with alcohol dependence', Neuropsychologia, vol. 30, pp. 427 - 435, http://dx.doi.org/10.1016/0028-3932(92)90090-9

RITTER AJ; COLE MJ, 1992, 'Men's issues: gender role conflict and substance abuse', Drug and Alcohol Review, vol. 11, pp. 163 - 167, http://dx.doi.org/10.1080/09595239200185641

Bond NW; Homewood J; Bowden SC; Ritter AJ; Wodak A, 1991, 'Thiamine in our bread and wine [7]', Medical Journal of Australia, vol. 154, pp. 780 - 781, http://dx.doi.org/10.5694/j.1326-5377.1991.tb121339.x

Perez P; Dray A; Ritter A; Dietze P; Moore T; Mazerolle L, 2006, 'SimDrug: Exploring the complexity of illicit drug markets', in 50th Annual Meeting of the International Society for the Systems Sciences 2006, ISSS 2006, pp. 175 - 197

Ritter A, 2004, 'The 15th International Conference on the Reduction of Drug Related Harm, Melbourne, Australia, 20-24th April 2004', in International Journal of Drug Policy, pp. 311 - 314, http://dx.doi.org/10.1016/j.drugpo.2004.05.003

Ritter AJ, 2004, 'Drug dependence: Evidence-base for treatment and translating research into practice', in CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY, BLACKWELL PUBLISHING ASIA, AUSTRALIA, Brisbane, pp. A218 - A218, presented at 8th World Congress of Clinical Pharmacology and Therapeutics, AUSTRALIA, Brisbane, 01 August 2004 - 06 August 2004, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000225490400029&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Whetton S; Tait RJ; Cartwright K; Ferrante A; Gray D; Kaye S; McKetin R; Pidd K; Ritter A; Roche A; Allsop S, 2018, 'HARMS TO RESIDENT ADULTS AND ADULT FAMILY MEMBERS OF A PERSON DEPENDENT ON METHAMPHETAMINE: COUNTING THE COSTS', in DRUG AND ALCOHOL REVIEW, WILEY, Vol. 37, pp. S74 - S75, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000449495000183&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Barratt MJ; Bruno R; Ezard N; Ritter A, 2016, 'THE FEASIBILITY OF USER-SUBMITTED DRUG OR PILL TESTING SERVICES IN AUSTRALIA', in DRUG AND ALCOHOL REVIEW, WILEY, Vol. 35, pp. 25 - 25, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000398381500068&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Ritter A, 2014, 'JAMES RANKIN ORATION: THE CHALLENGES OF POLICY RESEARCH THAT AIMS TO MAKE A DIFFERENCE', in DRUG AND ALCOHOL REVIEW, WILEY-BLACKWELL, Vol. 33, pp. 1 - 1, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000344914800002&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Scott N; Caulkins JP; Dietze P; Ritter A, 2014, 'PATTERNS OF DRUG PREFERENCE AND USE AMONG PEOPLE WHO INJECT DRUGS IN VICTORIA', in DRUG AND ALCOHOL REVIEW, WILEY-BLACKWELL, Vol. 33, pp. 56 - 56, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000344914800161&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Lancaster K; Duke K; Ritter A, 2014, 'EXAMINING THE CONSTRUCTION AND REPRESENTATION OF 'RECOVERY' IN UNITED KINGDOM AND AUSTRALIAN DRUG POLICY DISCUSSIONS', in DRUG AND ALCOHOL REVIEW, WILEY-BLACKWELL, Vol. 33, pp. 38 - 38, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000344914800110&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Vuong T; Larney S; Ritter A, 2020, A Data Linkage Evaluation of the Outcomes of the NSW Involuntary Drug and Alcohol Treatment (IDAT) Program, UNSW Social Policy Research Centre, Sydney, DPMP Monograph No. 33, http://dx.doi.org/10.26190/n165-xq68

Hughes C; Seaar K; Ritter A; Mazerolle L, 2019, Monograph No. 27: Criminal justice responses relating to personal use and possession of illicit drugs: The reach of Australian drug diversion programs and barriers and facilitators to expansion, National Drug and Alcohol Research Centre, UNSW Sydney, Sydney, http://dx.doi.org/10.26190/5cca661ce09ce

Vuong T; Ritter A; Hughes C; Shanahan M; Barrett L, 2019, Mandatory alcohol and drug treatment: What is it and does it work?, UNSW Sydney, Sydney, http://dx.doi.org/10.26190/5cc258e2a385c

Vuong T; Sotade O; Beadman K; Ritter A, 2019, An evaluation of outcomes in the NSW Involuntary Drug and Alcohol Treatment (IDAT) Program, UNSW Social Policy Research Centre, Sydney, DPMP Monograph No. 32, http://dx.doi.org/10.26190/xfs9-9z04

Ritter A; Hughes C; Shanahan M, 2018, Bulletin No. 26: Models for the Decriminalisation of the Personal Use and Possession of Drugs, Social Policy Research Centre, UNSW Sydney, Sydney, http://dx.doi.org/10.26190/5beba8750ca19

Lancaster K; Seear K; Ritter A, 2018, Monograph No. 26: Reducing Stigma and Discrimination for People Experiencing Problematic Alcohol and Other Drug Use, National Drug and Alcohol Research Centre, Sydney, DPMP Monograph Series, 26, http://dx.doi.org/10.26190/5b8746fe72507

Hughes CE; Ritter A, 2018, DPMP Bulletin No. 25: What does the research evidence tell us about what Australians think about the legal status of drugs? A 2018 update, National Drug and Alcohol Research Centre and Social Policy Research Centre, Sydney, DPMP Bulletin Series

Hughes C; Ritter A, 2018, Bulletin No. 25: What does the research evidence tell us about what Australians think about the legal status of drugs? A 2018 update, National Drug and Alcohol Research Centre, UNSW Sydney, Sydney, Drug Policy Modelling Program Bulletin Series

Vuong T; Shanahan M; Oluwadamisola S; Ritter A, 2018, A Cost Assessment of the NSW Involuntary Drug and Alcohol Treatment (IDAT) Program. Report to the NSW Ministry of Health

Lancaster K; Ritter A; Seear K, 2018, Reducing stigma and discrimination for people experiencing problematic alcohol and other drug use, QMHC, https://www.qmhc.qld.gov.au/sites/default/files/downloads/reducing_stigma_and_discrimination_for_people_experiencing_problematic_alcohol_and_other_drugs_ndarc_april_2017_0.pdf

Vuong T; Shanahan M; Sotade O; Ritter A, 2018, A Cost Assessment of the NSW Involuntary Drug and Alcohol Treatment (IDAT) Program, UNSW Social Policy Research Centre, Sydney, DPMP Monograph No. 31, http://dx.doi.org/10.26190/pn48-m053

Leung J; Stockings EA; Wong I; Galasyuk N; Diminic S; Leitch E; Whiteford H; Degenhardt L; Ritter A; Harris M, 2017, Co-morbid mental and substance use disorders – a meta-review of treatment effectiveness, National Drug and Alcohol Research Centre, 336

Ritter A; van de Ven K, 2017, Phase 1 of the development of a National Treatment Framework for drug and alcohol treatment services, Commonwealth Department of Health

Hughes CE; Shanahan M; Sotade O; Ritter A, 2017, Towards a new ACT Drug and Alcohol Court: A program and systems perspective, Drug Policy Modelling Program, NDARC, UNSW, Sydney

Vuong T; Ritter A; Shanahan M, 2017, Process Evaluation of the NSW Involuntary Drug and Alcohol Treatment (IDAT) Program, UNSW Social Policy Research Centre, Sydney, DPMP Monograph No. 30, http://dx.doi.org/10.26190/pkmb-de30

Ritter A; Lancaster KS; Barratt M, 2016, Researcher engagement with people who use drugs, Drug and Alcohol Research Connections, Drug and Alcohol Research Connections, http://connections.edu.au/opinion/researcher-engagement-people-who-use-drugs

Hughes C; Ritter A; Chalmers J; Lancaster K; Barratt M; Moxham-Hall V, 2016, Decriminalisation of drug use and possession in Australia – A briefing note, Drug Policy Modelling Program, NDARC, UNSW Australia, Sydney, https://dpmp.unsw.edu.au/resource/decriminalisation-drug-use-and-possession-australia-%E2%80%93-briefing-note

Hughes C; Cowdery N; Ritter A, 2015, DPMP briefing paper: Australian drug trafficking laws: guilty until proven innocent?, National Drug & Alcohol Research Centre, Sydney

Barratt M; Kowalski M; Maier L; Ritter A, 2015, Bulletin no. 24: Global review of drug checking services operating in 2017, National Drug & Alcohol Research Centre, Sydney

Belackova V; Ritter A; Shanahan M; Chalmers J; Hughes C; Barratt MJ; Lancaster K, 2015, Medicinal cannabis in Australia – Framing the regulatory options

Berends L; Ritter A, 2014, The processes of reform in Victoria's alcohol and other drug sector, 2011-2014, National Drug and Alcohol Research Centre, Sydney, http://apo.org.au/node/54073

Hughes C; Shanahan M; Ritter A; McDonald D; Gray-Weale F, 2014, Monograph No. 25: Evaluation of Australian Capital Territory drug diversion programs, National Drug and Alcohol Research Centre, Sydney, Drug Policy Modelling Program Monograph Series

Hughes C; Ritter A; Cowdery N; Phillips B, 2014, Australian threshold quantities for 'drug trafficking': Are they placing drug users at risk of unjustified sanction, Australian Institute of Criminology, Canberra, http://www.aic.gov.au/publications/current%20series/tandi/461-480/tandi467.html

Ritter A; Berends L; Chalmers J; Hull P; Lancaster K; Gomez M, 2014, New Horizons: The Review of Alcohol and Other Drug Treatment Services in Australia, Commonwealth Department of Health and Ageing

Hughes CE; Shanahan M; Ritter A; McDonald D; Gray-Weale F, 2014, Monograph No. 25: Evaluation of the ACT drug diversion programs, National Drug and Alcohol Research Centre, Sydney, DPMP Monograph Series, https://ndarc.med.unsw.edu.au/sites/default/files/ndarc/resources/DPMP%20MONO%2025.pdf

Hughes CE; Ritter A; Cowdery N; Phillips B, 2014, Evaluating Australian drug trafficking thresholds: Proportionate, equitable and just?, Criminology Research Advisory Council, Canberra, http://crg.aic.gov.au/reports/1314/35-1112-FinalReport.pdf

Chalmers J; Ritter A, 2014, Alcohol and other drug treatment utilisation in Australia. Working Paper No. 8.

Chalmers J; Ritter A; Berends L, 2014, Alcohol and other drug treatment financing in Australia: Funding flows. Working Paper No. 3, Drug Policy Modelling Program, National Drug and Alcohol Research Centre, University of New South Wales, Sydney

Ritter A; Gomez M, 2014, Hard to count” or unrecorded treatment utilisation for alcohol and other drugs. Working Paper No. 6, Drug Policy Modelling Program, National Drug and Alcohol Research Centre, University of New South Wales, Sydney

Ritter A; Hull P, 2014, The potential role of pay-for-performance in alcohol and other drug treatment funding: a literature review. Working Paper No. 5, Drug Policy Modelling Program, National Drug and Alcohol Research Centre, University of New South Wales., Sydney

Ritter A; Chalmers J; Sunderland M, 2014, Estimating need and demand for treatment – a background briefing. Working Paper No. 1, Drug Policy Modelling Program, National Drug and Alcohol Research Centre, University of New South Wales, Sydney

Ritter A; Chalmers J; Berends L, 2014, Australian alcohol and other drug treatment spending. Working Paper No 7, Drug Policy Modelling Program, National Drug and Alcohol Research Centre, University of New South Wales, Sydney

Ritter A; Chalmers J; Berends L, 2014, The Non Government Organisation Treatment Grants Program (NGOTGP) and the Substance Misuse Service Delivery Grants Fund (SMSDGF) – a descriptive overview. Working Paper No. 4, Drug Policy Modelling Program, National Drug and Alcohol Research Centre, University of New South Wales, Sydney

Ritter A; Hull P; Berends L; Chalmers J, 2014, Approaches to purchasing alcohol and other drug treatment in Australia. Working Paper No. 10, Drug Policy Modelling Program, National Drug and Alcohol Research Centre, University of New South Wales, Sydney

Ritter A; Hull P; Berends L; Chalmers J, 2014, Planning processes for alcohol and other drug treatment in Australia. Working Paper No. 9, Drug Policy Modelling Program, National Drug and Alcohol Research Centre, University of New South Wales, Sydney

Ritter A; McLeod R; Shanahan M, 2013, Monograph No. 24: Government drug policy expenditure in Australia -2009/10, National Drug and Alcohol Research Centre, Sydney, Drug Policy Modelling Program Monograph Series

Vel-Palumbo MD; Matthew-Simmons F; Shanahan M; Ritter A, 2013, Bulletin No. 22: Supervised Injecting Facilities: What the literature tells us, National Drug & Alcohol Research Centre, Sydney, Drug Policy Modelling Program Bulletin Series

Lancaster KS; Ritter A; Matthew-Simmons F, 2013, Young people's opinions on alcohol and other drugs issues, Australian National Council on Drugs, Australian National Council on Drugs, ANCD Research Paper No.27, https://ndarc.med.unsw.edu.au/sites/default/files/newsevents/events/RP27-young-peoples-opinions.pdf

Ritter A; Roxburgh A; Slade T; Burns L, 2013, Trends in drug use and related harms in Australia, 2001 to 2013, Drug Policy Modelling Program. National Drug and Alcohol Research Centre, UNSW, Sydney

Ritter A; Chalmers J, 2013, Modelling alternate opioid treatment system configurations, Drug Policy Modelling Program, Sydney

Ritter A; McLeod R; Shanahan M, 2013, Monograph No. 24: Government drug policy expenditure in Australia – 2009/10, National Drug and Alcohol Research Centre, Sydney, DPMP Monograph Series, https://ndarc.med.unsw.edu.au/sites/default/files/ndarc/resources/24%20Government%20drug%20policy%20expenditure%20in%20Australia%20-%202009_10.pdf

Chalmers J; Phillips B; Gray-Weale F; Ritter A, 2013, Treatment pathways from the client’s perspective: Informing a better match between servicer provision and service need, National Drug and Alcohol Research Centre, Sydney

Ritter A; Matthew-Simmons F; Carragher N, 2012, Monograph No. 23: Prevalence of and interventions for mental health and alcohol and other drug problems amongst the gay, lesbian, bisexual and transgender community: A review of the literature, National Drug and Alcohol Research Centre, Sydney, Drug Policy Modelling Program Monograph Series

Ritter A; Matthew-Simmons F, 2012, Bulletin No. 21: What does the research evidence tell us about what Australians think about the legal status of drugs?, National Drug & Alcohol Research Centre, Sydney, Drug Policy Modelling Program Bulletin Series

Ritter A; Bright DA; Gong W, 2012, Evaluating drug law enforcement interventions directed towards methamphetamine in Australia, National Drug Law Enforcement Research Fund, Canberra, NDLERF Monograph Series, 44, http://www.ndlerf.gov.au/pub/Monograph_44.pdf

Ritter A; Matthew-Simmons F; Carragher N, 2012, Monograph No. 23: Prevalence of and interventions for mental health and alcohol and other drug problems amongst the gay, lesbian, bisexual and transgender community: a review of the literature, National Drug and Alcohol Research Centre, Sydney, https://dpmp.unsw.edu.au/sites/default/files/dpmp/resources/DPMP%20MONO%2023.pdf

Ritter A; Sunderland M; Chalmers J, 2012, Estimating the unmet need and unmet demand for opioid treatment in NSW, National Drug and Alcohol Research Centre, Sydney

Ritter A; Sunderland M, 2012, YSAS service planning project: Estimating need for youth services, National Drug and Alcohol Research Centre, Sydney

Hughes C; Ritter A, 2011, Monograph No. 22: Legal thresholds for serious drug offences: Expert advice to the ACT on determining amounts for trafficable, commercial and large commercial drug offences, National Drug and Alcohol Research Centre, Sydney, Drug Policy Modelling Program Monograph Series

Ritter A; Lancaster K; Grech K; Reuter P, 2011, Monograph No. 21: An assessment of illicit drug policy in Australia (1985-2010): Themes and trends, National Drug and Alcohol Research Centre, Sydney, Drug Policy Modelling Program Monograph Series

Hughes CE; Ritter A, 2011, Monograph No. 22: Legal thresholds for serious drug offences: Expert advice to the ACT on determining amounts for trafficable, commercial and large commercial drug offences, National Drug and Alcohol Reseach Centre, Sydney, DPMP Monograph Series, https://dpmp.unsw.edu.au/sites/default/files/dpmp/resources/22%20Legal%20thresholds%20for%20serious%20drug%20offences.pdf

King T; Ritter A; Berends L, 2011, Victorian Pharmacotherapy Review, National Drug and Alcohol Research Centre, Sydney

Chalmers J; Lancaster K; Ritter A; King T, 2011, Pharmacy participation in NSW Opioid Treatment Program: Options paper, A report prepared for NSW Health, National Drug and Alcohol Research Centre, Sydney

Ritter A; Lancaster K; Grech K; Reuter P, 2011, Monograph No. 21: An assessment of illicit drug policy in Australia (1985-2010): Themes and trends, National Drug and Alcohol Research Centre, Sydney, DPMP Monograph Series

Ngui R; Shanahan M, 2010, Monograph No. 20: Cannabis use disorder treatment and associated health care costs in New South Wales, 2007, National Drug and Alcohol Research Centre, Sydney

Hughes C; Spicer B; Lancaster K; Matthew-Simmons F; Dillon P, 2010, Bulletin No. 20: Drugs in the Australian news media: Trends and impacts on youth attitudes to illicit drug use, National Drug & Alcohol Research Centre, Sydney, Drug Policy Modelling Program Bulletin Series

Hughes C; Spicer B; Lancaster K; Matthew-Simmons F; Dillon P, 2010, Monograph No. 19: Media reporting on illicit drugs in Australia: Trends and impacts on youth attitudes to illicit drug use, National Drug and Alcohol Research Centre, Sydney, Drug Policy Modelling Program Monograph Series

Mathew-Simmons F; Shanahan M; Ritter A, 2010, Bulletin No. 19: Estimating the street value of a cannabis plant in Australia, Drug Policy Modelling Program Bulletin Series

Hughes C, 2010, Bulletin No. 18: Legislative thresholds for drug possession and traffic: An overview of state and territory differences in Australia, National Drug & Alcohol Research Centre, Sydney

Hughes C; Lodge M; Ritter A; McDonald D, 2010, Monograph No. 18: The coordination of Australian illicit drug policy: A governance perspective, National Drug and Alcohol Research Centre, Sydney, Drug Policy Modelling Program Monograph Series

Hughes C; Lodge M; Ritter A, 2010, Monograph No. 18: The Coordination of Australian Illicit Drug Policy: A governance perspective, National Drug and Alcohol Research Centre, University of New South Wales, Sydney, NSW, Original, https://ndarc.med.unsw.edu.au/sites/default/files/ndarc/resources/18%20The%20coordination%20of%20Australian%20illicit%20drug%20policy.pdf

Hughes C; Ritter A, 2010, Diversion of drug offenders - Report for Queensland Health and Queesland Police, Drug Policy Modelling Program, Sydney

Ritter A; Chalmers J, 2009, Polygon: The many sides to Australian opioid pharmacotherapy maintenance system, Australian National Council on Drugs, Canberra, ANCD Research Paper 18

Chalmers J; Ritter A; Heffernan M; McDonnell G, 2009, Modelling pharmacotherapy maintenance in Australia: exploring affordability, availability, accessibility and quality using system dynamics, Australian National Council on Drugs, Canberra, ANCD Research Paper 19

Ritter A, 2009, Situation of drug related research in Australia., Directorate-General for Justice, Freedom and Security of the European Commission, In G. Buhringer, M. Farrell, L. Kraus, J. Marsden, T. Pfeiffer-Gerschel, D. Piontek, K. Karachaliou, J. Kunzel & G. Stillwell. Comparative Analysis of Research into Illicit Drugs in the European Union

Matthew-Simmons F; Love S; Ritter A, 2008, Monograph No. 17: A review of Australian public opinion surveys on illicit drugs, National Drug and Alcohol Research Centre, Sydney, Drug Policy Modelling Program Monograph Series

Hughes C; Ritter A, 2008, Monograph No. 16: A summary of diversion programs for drug and drug-related offenders in Australia, National Drug and Alcohol Research Centre, Sydney, Drug Policy Modelling Program Monograph Series

Hughes C; Ritter A, 2008, Monograph No. 16: A summary of diversion programs for drug and drug related offenders in Australia, National Drug and Alcohol Research Centre, Sydney, Original, https://dpmp.unsw.edu.au/resource/16-summary-diversion-programs-drug-and-drug-related-offenders-australia

Matthew-Simmons F; Love S; Ritter A, 2008, Monograph No. 17: A review of Australian public opinion surveys on illicit drugs, National Drug and Alcohol Research Centre, Sydney, DPMP Monograph Series

Ritter A, 2007, Bulletin No. 17: Priority areas in illicit drug policy: Perspectives of policy makers, National Drug & Alcohol Research Centre, Sydney, Drug Policy Modelling Program Bulletin Series

Ritter A, 2007, Bulletin No. 16: Drug Policy Modelling Program overview, National Drug & Alcohol Research Centre, Sydney, Drug Policy Modelling Program Bulletin Series

Ritter A, 2007, Monograph No. 15: Priority areas in illicit drug policy: Perspectives of policy makers, National Drug and Alcohol Research Centre, Sydney, Drug Policy Modelling Program Monograph Series

Moore T, 2007, Monograph No. 14: Working estimates of the social costs per gram and per user for cannabis, cocaine, opiates and amphetamines, National Drug and Alcohol Research Centre, Sydney

Lee N; Jenner L; Kay-Lambkin F; Hall K; Dan F; Roeg S; Hunt S; Dingle G; Baker A; Hides L; Ritter A, 2007, PsyCheck: Responding to mental health issues within alcohol and drug treatment, Commonwealth Australia, Canberra

Ritter A; McDonald D, 2005, Monograph No. 2: Drug policy interventions: A comprehensive list and a review of classification schemes, Turning Point Alcohol and Drug Centre Inc, Fitzroy, Drug Policy Modelling Project Monograph Series

Ritter A; Cameron J, 2005, Monograph No. 6: A systematic review of harm reduction, Turning Point Alcohol and Drug Centre, Fitzroy, Drug Policy Modelling Project Monograph Series

Ritter A, 2005, Monograph No. 8: A review of approaches to studying illicit drug markets, Turning Point Alcohol and Drug Centre, Fitzroy, Drug Policy Modelling Project Monograph Series

Moore TJ; Caulkins JP; Ritter A; Dietze P; Monagle S; Pruden J, 2005, Monograph No. 9: Heroin markets in Australia: Current understandings and future possibilities, Turning Point Alcohol and Drug Centre, Fitzroy, Drug Policy Modelling Project Monograph Series

Perez P; Dray A; Ritter A; Dietze P; Moore T; Mazerolle L, 2005, Monograph No. 11: SimDrug: Exploring the complexity of heroin use in Melbourne, Turning Point Alcohol and Drug Centre, Fitzroy, Drug Policy Modelling Project Monograph Series

Moore T, 2005, Monograph No. 1: What is Australia's "drug budget"? The policy mix of illicit drug-related government spending in Australia, Turning Point Alcohol and Drug Centre Inc., Fitzroy, Victoria, 1

Dietze P; Hickman M; Kimber J, 2005, Monograph No. 3: Estimating the prevalence of problematic heroin use in Melbourne, Turning Point Alcohol and Drug Centre Inc, Fitzroy

McDonald D; Bammer G; Breen G, 2005, Monograph No. 4: Australian illicit drugs policy: Mapping structures and processes, Turning Point Alcohol and Drug Centre Inc, Fitzroy

Mazerolle L; Soole D; Rombouts S, 2005, Monograph No. 5: Drug law enforcement: The evidence, Turning Point Alcohol and Drug Centre, Fitzroy

Soole DW; Mazerolle L; Rombouts S, 2005, Monograph No. 7: School based drug prevention: A systematic review of the effectiveness on illicit drug use, Turning Point Alcohol and Drug Centre, Fitzroy

Degenhardt L; Dietze P, 2005, Monograph No. 10: DATA SOURCES ON ILLICIT DRUG USE AND HARM IN AUSTRALIA, Turning Point Alcohol and Drug Centre, Fitzroy

Dance P; Strachan A; Deane P; Bammer G, 2005, Monograph No. 12: Popular culture and the prevention of illicit drug use: A pilot study of popular music and the acceptability of drugs, Turning Point Alcohol and Drug Centre, Fitzroy

Midgley G; Winstanley A; Gregory W; Foote J, 2005, Monograph No. 13: Scoping the potential uses of systems thinking in developing policy on illcit drugs, Turning Point Alcohol and Drug Centre, Fitzroy

J. Moore T, 2005, Monograph No. 1: What is Australia's "drug budget"? The policy mix of illicit drug-related government spending in Australia, Turning Point Alcohol and Drug Centre, Fitzroy

Ritter A; McDonald D, 2005, Bulletin No. 3: Drug policy response schema, Turning Point Alcohol and Drug Centre, Fitzroy, Drug Policy Modelling Program Bulletin Series

Moore T; Ritter A; Caulkins J, 2005, Bulletin No. 10: Economic modelling: Cost-effectiveness of three policy options, Turning Point Alcohol and Drug Centre, Fitzroy, Drug Policy Modelling Program Bulletin Series

Bammer G; McDonald D; Breen G, 2005, Bulletin No.1: Drug Policy - Mapping structures and enhancing processes, Turning Point Alcohol and Drug Centre, Fitzroy

Bammer G, 2005, Bulletin No. 2: Exploring executive sessions to generate effective new approaches to illicit drugs, Turning Point Alcohol and Drug Centre, Fitzroy

Mazerolle L; Soole D; Rombouts S, 2005, Bulletin No. 4: Review of drug law enforcement interventions, Turning Point Alcohol and Drug Centre, Fitzroy

Dietze P; Hickman M; Kimber J, 2005, Bulletin No. 5: Estimating the number of heroin users in Australia, Turning Point Alcohol and Drug Centre, Fitzroy

Moore T; Caulkins J; Dietze P, 2005, Bulletin No. 6: Illicit drugs in Australia: What do we know about the role of price?, Turning Point Alcohol and Drug Centre, Fitzroy

Moore T, 2005, Bulletin No. 8: The impact of heroin seizures (Economic back of the envelope calculations), Turning Point Alcohol and Drug Centre, Fitzroy

Midgley G; Winstanley A; Gregory W; Foote J, 2005, Bulletin No. 9: Scoping the potential uses of systems thinking in developing policy on illicit drugs, Turning Point Alcohol and Drug Centre, Fitzroy

Dietze P; Stoove M; Caulkins J, 2005, Bulletin No. 12: System dynamics modelling using a stocks and flows approach, Turning Point Alcohol and Drug Centre, Fitzroy

Bammer G; Dance P, 2005, Bulletin No. 13: Popular culture and the prevention of illicit drug use, Turning Point Alcohol and Drug Centre, Fitzroy

Bammer G, 2005, Bulletin No. 14: Improving methods to deal with uncertainty in illicit drug policy formulation, Turning Point Alcohol and Drug Centre, Fitzroy

Bammer G; Deane P, 2005, Bulletin No. 15: Integration in DPMP: An organising principle and an expanded set of tools, Turning Point Alcohol and Drug Centre, Fitzroy

Shanahan M; Havard A; Mills K; Williamson A; Ross J; Teesson M; Darke S; Ali R; Ritter A; Cooke R; Lynskey M, 2003, Health services use and treatment costs over 12 months among heroin users: Findings from the Australian Treatment Outcome Study (ATOS), National Drug and Alcohol Research Centre, University of New South Wales, Sydney, NSW, Australia, NDARC Technical Report No. 203, https://ndarc.med.unsw.edu.au/sites/default/files/ndarc/resources/TR.203.pdf